Trend-Following Backtester · Guide · backtest 한국어

equity · US

Arcutis Biotherapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Arcutis Biotherapeutics, Inc.. 8 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 15.0%, MDD -26.3%).

Data 2020-01-31 ~ 2026-07-31daily bars 1,633 (6.5 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

8 of 10 beat buy and hold (CAGR 3.2%, drawdown -95.0%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 23.6%, MDD -42.2%, Sharpe 0.83, 11% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 20.4%p higher than buy and hold, while drawdown improves by 52.8%p (CAGR 15.0%, MDD -26.3%, exposure 7%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=21, threshold=29
23.6%-42.2%0.830.564.0x1011%
Keltner 채널 돌파
emaPeriod=33, atrPeriod=9, mult=3.8
15.0%-26.3%0.690.572.5x47%
볼린저 밴드 돌파
n=40, k=3
17.6%-42.9%0.650.412.9x1417%
SMA 크로스오버
fast=56, slow=158
13.6%-57.3%0.500.242.3x646%
Donchian 채널 돌파
entryN=22, exitN=91
13.0%-76.5%0.500.172.2x1571%
EMA 크로스오버
fast=50, slow=210
13.0%-53.3%0.490.242.2x549%
Supertrend
period=12, mult=4.6
11.8%-79.0%0.480.152.1x1761%
ROC 모멘텀
n=130, threshold=-0.03
3.5%-64.7%0.310.051.2x4748%
MACD
fast=13, slow=51, signal=7
-0.2%-72.1%0.25-0.001.0x11449%
Parabolic SAR
step=0.005, maxStep=0.32
-2.1%-84.1%0.23-0.030.9x5751%
Buy and hold3.2%-95.0%0.420.031.2x1100%
0.1 1x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -24% -48% -71% -95% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -42.2% (2024-04-08 → 2025-10-27), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupAll asset reports

Read next